Funding for this research was provided by:
Foundation for the National Institutes of Health (UG3CA244298)
National Cancer Institute (1K07CA211971-01A1)
Received: 30 January 2022
Accepted: 19 March 2022
First Online: 13 April 2022
: The study protocol was reviewed and approved by the Institutional Review Board at Oregon Health & Science University and was granted a waiver of informed consent, given minimal risks to patients.
: All authors have reviewed a final version of this manuscript and provide consent for its publication.
: From 2020 to the present, Dr. Coronado serves as a Scientific Advisor on contracts through the Center for Health Research for Exact Sciences and Guardant Health. She also serves as a member of the Board of Scientific Advisors for the National Cancer Institute (NCI).